|
Post by yash on Aug 9, 2017 7:22:37 GMT -5
sg.finance.yahoo.com/news/featured-company-news-mannkind-one-110000971.htmlMannKind and One Drop Announce Collaboration to Deliver a Unified Solution for Diabetes Patients LONDON, UK / ACCESSWIRE / August 9, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for MannKind Corp. (NASDAQ: MNKD), following which we have published a free report that can be viewed by signing up at protraderdaily.com/optin/?symbol=MNKD. The Company and One Drop announced on August 07, 2017, the first step of their collaboration with the launch of A-ONE study, a randomized controlled trial investigating the use of Afrezza inhaled insulin and One Drop's integrated digital diabetes care platform. One Drop is a unique, fully integrated solution with the prospects of a huge health benefit. The combination of One Drop with inhaled insulin is expected to offer consumers, health care providers, and payers a potentially powerful solution with unprecedented benefits. One Drop, also known as Informed Data Systems, Inc., is a digital health Company, leveraging the power of mobile computing and data science to transform the lives of people with diabetes.
|
|